Behavioral and Psychiatric Adverse Events Associated With Antiepileptic Drugs Commonly Used in Pediatric Patients
- 1 August 2004
- journal article
- review article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 19 (1S) , S25-S38
Abstract
Multiple factors—including the efficacy of the antiepileptic drug for the particular seizure type, availability of pediatrics-friendly formulations, the ease of dosing and titration, and tolerability issues, such as possible drug interactions and adverse events—affect the selection of the best antiepileptic drug for a child with epilepsy. Behavioral problems are common in children with epilepsy and can be aggravated or initiated by antiepileptic drug therapy. The types and frequencies of antiepileptic drug-associated behavioral events can influence a clinician's drug selection, drug management, and counseling of parents. Unfortunately, appreciating differences among antiepileptic drugs in behavioral adverse event profiles is problematic because, among other reasons, methodologies for reporting, collecting, and analyzing adverse events are not uniform across trials, and there is marked heterogeneity in study design among trials. This review summarizes incidence rates for behavioral and psychiatric adverse events taken from studies of children with epilepsy. These rates are reported for the 10 most commonly prescribed antiepileptic drugs (valproic acid, carbamazepine, phenobarbital, lamotrigine, phenytoin, levetiracetam, oxcarbazepine, topiramate, zonisamide, and gabapentin), grouped according to their predominant mechanism of action. Despite the numerous methodologic inconsistencies, some similarities in adverse event profiles among antiepileptic drugs that share mechanisms of action are apparent. Moreover, the overwhelming body of data on the behavioral effects of phenobarbital should convince clinicians that, whenever possible, it should not be used as the initial—or even the second—monotherapy in children with epilepsy. (J Child Neurol 2004;19(Suppl 1):S25-S38).Keywords
This publication has 65 references indexed in Scilit:
- Oxcarbazepine in the treatment of childhood epilepsyPediatric Neurology, 2003
- Treatment of epilepsy in the multiply handicappedMental Retardation and Developmental Disabilities Research Reviews, 2000
- Gabapentin as Add‐On Therapy in Children with Refractory Partial Seizures: A 12‐Week, Multicentre, Double‐Blind, Placebo‐Controlled StudyEpilepsia, 1999
- The Efficacy of Lamotrigine in Children and Adolescents with Refractory Generalized Epilepsy: A Randomized, Double‐Blind, Crossover StudyEpilepsia, 1998
- Efficacy of gabapentin therapy in children with refractory partial seizuresThe Journal of Pediatrics, 1996
- Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine, or sodium valproate for newly diagnosed childhood epilepsyThe Lancet, 1996
- Lamotrigine for the treatment of epilepsy in childhoodThe Journal of Pediatrics, 1995
- Adverse behavioral reactions in children treated with carbamazepine (Tegretol)The Journal of Pediatrics, 1982
- INFLUENCE OF PHENOBARBITAL ON THE PSYCHOMOTOR DEVELOPMENT AND BEHAVIOUR IN PRESCHOOL CHILDREN WITH CONVULSIONS1Neuropediatrics, 1980
- Side effects of phenobarbital in toddlers; behavioral and cognitive aspectsThe Journal of Pediatrics, 1979